EFFECTS OF XENICAL ON LPL AND HTGL FOLLOWING A FAT RICH BREAKFAST
EFFECTS OF XENICAL ON LPL AND HTGL FOLLOWING A FAT RICH BREAKFAST
批准号:
2783967
负责人:
金额:
$3.28万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Xenical (orlistat) is a new anti-obesity drug which limits fat absorption
by the inhibition of pancreatic lipase (PL) activity. Xenical may inhibit
systemic plasma lipases as well as gastrointestinal lipases. The effect
or lack thereof that Xenical or its metabolites have on lipoprotein
lipase (LPL) and hepatic triglyceride lipase (HTGL) activity during the
time triglycerides appear in the circulation after eating needs to be
established. Therefore, the effects of Xenical and its metabolites on
postprandial pre-and postheparin LPL and HTGL activities and on
postprandial plasma lipoprotein concentrations were examined in this
clinical trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金